CClinicalTrials.gg
CompletedNCT00365482Updated May 17, 2012

Bipolar Disorder in Epilepsy

An observational study in Epilepsy and Bipolar Disorder, sponsored by Northwell Health. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2012-05-17.

Sponsored by Northwell Health · Observational

Study type
Observational
Model
Case-only
Time perspective
Prospective
Enrollment
102
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to find out how often major mood swings occur in patients treated in a specialty epilepsy center.

Read the detailed description

Bipolar disorder (a condition of major mood swings) or milder forms of ups and downs in mood may occur with a number to neurological conditions. Recently, one study showed that these mood changes occur fairly often in individuals with epilepsy studied in the general community. We speculate that bipolar symptoms occur with even higher frequency in a tertiary epilepsy center than that encountered in the previous community-based study. The goals of this study are to assess:

  • the rate of bipolar symptoms as measured by a self-reporting screening tool in a tertiary epilepsy center setting
  • the meaning of a positive screening score in epilepsy patients
  • the utility, sensitivity and specificity of alternative screening tools for mood instability in epilepsy patients
  • the correlation of mood instability with seizure-related variables
  • the relation of a positive screening score on quality of life.
02

Conditions studied

  • Epilepsy
  • Bipolar Disorder

Keywords

  • Epilepsy
  • Bipolar Disorder
03

In context

Epilepsy

1,805 studies on the registry are indexed under Epilepsy; 417 are open to participants now.

This study's enrollment of 102 is close to the median of 102 across 521 observational studies indexed under Epilepsy.

Browse Epilepsy studies →

Lead sponsor

Northwell Health is the lead sponsor of 463 studies on the registry; 109 are open to participants now.

Of its 40 completed or terminated interventional studies of FDA-regulated products, 20 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Epilepsy patients at the Long Island Jewish Comprehensive Epilepsy Center

Inclusion criteria

  • Male or female 18 years of age or older
  • Being evaluated at the Long Island Jewish Comprehensive Epilepsy Center
  • Capable of completing self-reporting questionnaires

Exclusion criteria

Exclusion Criteria:

  • Patients with mental retardation
  • Patients with pseudoseizures
05

Study design

Observational model
Case-only
Time perspective
Prospective
Enrollment
102 participants (actual)
06

Study locations

1 site
  • North Shore Long Island Jewish Health System
    Great Neck, New York 11021, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 17, 2012, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00365482
Lead sponsor
Northwell Health
Collaborators
GlaxoSmithKline
Responsible party
Sponsor
First posted
Aug 17, 2006
Start date
Aug 2006
Primary completion
Dec 2011
Completion
Dec 2011
Last update
May 17, 2012

Study contacts

Sean Hwang, MD
principal investigator · Long Island Jewish Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2012. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion